2023. In-silico Studies of Heterocyclic Benzoxazole Derivatives as an Anticancer Agent: Molecular Docking, 2D and 3D QSAR . International Journal of Pharmaceutical Sciences and Drug Research. 15, 6 (Nov. 2023), 780–788. DOI:https://doi.org/10.25004/IJPSDR.2023.150612.